|
Volumn 319, Issue 2, 2018, Pages 115-116
|
Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
THIAZIDE DIURETIC AGENT;
ACUTE KIDNEY FAILURE;
ALCOHOL CONSUMPTION;
BLOOD PRESSURE MONITORING;
BLOOD PRESSURE REGULATION;
BODY WEIGHT LOSS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
COMORBIDITY;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
ELECTROLYTE DISTURBANCE;
EXERCISE;
FAINTNESS;
FOLLOW UP;
HEALTH CARE SYSTEM;
HEALTH SERVICE;
HEALTHY DIET;
HUMAN;
HYPERTENSION;
HYPOTENSION;
INCIDENCE;
INTENTION TO TREAT ANALYSIS;
LIFE EXPECTANCY;
LIFESTYLE MODIFICATION;
MEDICAL SOCIETY;
MORTALITY;
POTASSIUM INTAKE;
PRACTICE GUIDELINE;
PREDICTION;
PRIORITY JOURNAL;
QUALITY CONTROL;
QUALITY OF LIFE;
RISK ASSESSMENT;
SHORT SURVEY;
SODIUM INTAKE;
SYSTOLIC BLOOD PRESSURE;
THERAPY EFFECT;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
AGED;
BLOOD PRESSURE;
MIDDLE AGED;
REFERENCE VALUE;
ADULT;
AGED;
AMERICAN HEART ASSOCIATION;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
PRACTICE GUIDELINES AS TOPIC;
REFERENCE VALUES;
SOCIETIES, MEDICAL;
UNITED STATES;
|
EID: 85040551920
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2017.19672 Document Type: Short Survey |
Times cited : (69)
|
References (10)
|